TATE Tate & Lyle plc
Tate & Lyle plc, together with its subsidiaries, engages in the provision of ingredients and solutions to the food, beverages, and other industries in North America, Asia, Middle East, Africa, Latin America, and Europe. Its portfolio includes sweeteners, fibres, stabilisers and functional systems, hydrocolloids, and starches, proteins, and functional flours. The company's products are used in beverages, dairy, soups, sauces and dressings, bakery and snacks, confectionery, household, clinical nutrition, industrial, meat and seafood, and personal care applications. The company has a strategic collaboration with BioHarvest Sciences Inc. The company was incorporated in 1903 and is headquartered in London, the United Kingdom.…
Industry Peers
Packaged FoodsKey Statistics
About Tate & Lyle (LON: TATE)
›
Tate & Lyle (LON: TATE) is listed on the London Stock Exchange, where its shares trade in pence sterling (GBp). It belongs to the Packaged Foods industry, part of the Consumer Defensive sector, and reports about 4,840 employees.
The shares were at 553.20 GBp on 20 November 2026, up 43.5% over 52 weeks. Its 52-week range is 319.40 GBp to 580.00 GBp: the price is 4.6% below the high and 73.2% above the low.
At a market capitalisation of 2.47B GBP, it trades at 34.8 times trailing earnings and 13.4 times forward earnings. The median trailing P/E of its 18 largest Packaged Foods peers is 24.8, a premium of 40% for TATE. It pays a dividend yielding 3.52% (it pays out 128% of its earnings), against a median of 3.60% among the dividend payers in that peer group.
Tate & Lyle reports return on equity of 6.1%, an operating margin of 11.6% and revenue up 1.5% year over year.
Its debt exceeds its cash by 970.00M GBP, a debt-to-equity ratio of 0.81. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 9 analysts cover the stock, with an average rating of Hold; their mean price target of 550.78 GBp is 0.4% below the current price. The next earnings report is expected on 27 May 2027.